Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rMenB+OMV NZ Vaccine Booster in Primed Adolescents and Young Adults
NCT06995430Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of Multicomponent meningococcal B vaccine in meningitis, sponsored by GSK. Started Jul 2025; status: completed.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
meningitis
Beyond the preview
Go deeper on NCT06995430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995430.